Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Impact of Drug Adherence/Persistence on Clinical Outcome in Various Breast Cancer Subtypes

NCT03761420 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT03761420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Impact of Drug Adherence/Persistence on Clinical Outcome in Various Breast Cancer Subtypes
Lead sponsor
St. Olavs Hospital
Phase
Observational
Overall status
Completed
Start date
August 1, 2019
Completion date
April 1, 2021
Enrollment
1,411 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm